education
|
points
Download App
Hong Kong
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Points
Download App
Country
Hong Kong
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
MIMS home
Drugs
Info
Alfinor
Alfinor
betahistine
Manufacturer:
Medochemie
Distributor:
Star Medical Supplies
Concise Prescribing Info
Contents
Betahistine diHCl
Indications/Uses
Vertigo, tinnitus & hearing loss associated w/ Meniere's syndrome.
Dosage/Direction for Use
Adult
Initially 8-16 mg tds. Maintenance: 24-48 mg daily.
Administration
Should be taken with food.
Contraindications
Phaeochromocytoma.
Special Precautions
History or active peptic ulcer, asthma. Pregnancy & lactation.
Adverse Reactions
GI disturbances including dyspepsia, headache, skin rash & pruritus.
View
ADR Reporting Link
MIMS Class
Antivertigo Drugs
/
Peripheral Vasodilators & Cerebral Activators
ATC Classification
N07CA01 - betahistine ; Belongs to the class of antivertigo preparations.
Regulatory Classification
P
1
S
1
S
3
Presentation/Packing
Form
Alfinor tab 8 mg
Packing/Price
10 × 10's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Continue with Google
OR
Sign up with email
Already a member?
Sign in